SEGMENT INFORMATION

3 Months Ended

Dec. 31, 2020

SEGMENT INFORMATION

SEGMENT INFORMATION

5.    SEGMENT INFORMATION

The Company operates in two principal segments - research services and research products. The Services segment provides research and development support on a contract basis directly to pharmaceutical companies. The Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions.  The accounting policies of these segments are the same as those described in the summary of significant accounting policies found in Note 2 to the Consolidated Financial Statements in our annual report on Form 10-K for the fiscal year ended September 30, 2020.

	Three Months Ended
	December 31,
	2020		2019
Revenue:
Service	$	17,032	$	12,142
Product		853		776
	$	17,885	$	12,918
Operating income (loss):
Service	$	3,111	$	1,263
Product		167		(271)
Corporate		(3,264)		(2,012)
	$	14	$	(1,020)
Interest expense		(347)		(311)
Other income		0		2
Loss before income taxes	$	(333)	$	(1,329)